The global market for Scopolamine Hydrobromide was valued at US$ 54.3 million in the year 2024 and is projected to reach a revised size of US$ 70.7 million by 2031, growing at a CAGR of 3.9% during the forecast period.

Scopolamine Hydrobromide Market

Scopolamine Hydrobromide is a muscarinic antagonist (anticholinergic drug) commonly used for the prevention of nausea and vomiting, particularly related to motion sickness or post-operative nausea. It is a salt form of scopolamine, which is an alkaloid obtained from the Solanaceae family of plants, notably the henbane plant. When in its hydrobromide form, scopolamine is more easily soluble in water, making it suitable for medical administration, either through transdermal patches, intravenous injections, or oral formulations.

North American market for Scopolamine Hydrobromide is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Scopolamine Hydrobromide is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Scopolamine Hydrobromide include Novartis, Mylan, Teva Pharmaceuticals, Baxter International, Sandoz, Amgen, Accord Healthcare, Manus Aktteva Biopharma, ALKALOIDS CORPORATION, Sigma-Aldrich, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Scopolamine Hydrobromide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Scopolamine Hydrobromide.

The Scopolamine Hydrobromide market size, estimations, and forecasts are provided in terms of sales volume (kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Scopolamine Hydrobromide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Scopolamine Hydrobromide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Scopolamine Hydrobromide Market Report

Report Metric	Details
Report Name	Scopolamine Hydrobromide Market
Accounted market size in year	US$ 54.3 million
Forecasted market size in 2031	US$ 70.7 million
CAGR	3.9%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Injections Oral Topical
Segment by Application	Hospital Clinic
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Novartis, Mylan, Teva Pharmaceuticals, Baxter International, Sandoz, Amgen, Accord Healthcare, Manus Aktteva Biopharma, ALKALOIDS CORPORATION, Sigma-Aldrich, TCI Chemicals, Tocris Bioscience, Alchem International, Glentham Life Sciences, ChemFaces, BioCrick, FUJIFILM Wako
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Scopolamine Hydrobromide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Scopolamine Hydrobromide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Scopolamine Hydrobromide Market growing?

Ans: The Scopolamine Hydrobromide Market witnessing a CAGR of 3.9% during the forecast period 2025-2031.

What is the Scopolamine Hydrobromide Market size in 2031?

Ans: The Scopolamine Hydrobromide Market size in 2031 will be US$ 70.7 million.

Who are the main players in the Scopolamine Hydrobromide Market report?

Ans: The main players in the Scopolamine Hydrobromide Market are Novartis, Mylan, Teva Pharmaceuticals, Baxter International, Sandoz, Amgen, Accord Healthcare, Manus Aktteva Biopharma, ALKALOIDS CORPORATION, Sigma-Aldrich, TCI Chemicals, Tocris Bioscience, Alchem International, Glentham Life Sciences, ChemFaces, BioCrick, FUJIFILM Wako

What are the Application segmentation covered in the Scopolamine Hydrobromide Market report?

Ans: The Applications covered in the Scopolamine Hydrobromide Market report are Hospital, Clinic

What are the Type segmentation covered in the Scopolamine Hydrobromide Market report?

Ans: The Types covered in the Scopolamine Hydrobromide Market report are Injections, Oral, Topical

1 Scopolamine Hydrobromide Market Overview

1.1 Product Definition

1.2 Scopolamine Hydrobromide by Type

1.2.1 Global Scopolamine Hydrobromide Market Value Comparison by Type (2024 VS 2031)

1.2.2 Injections

1.2.3 Oral

1.2.4 Topical

1.3 Scopolamine Hydrobromide by Application

1.3.1 Global Scopolamine Hydrobromide Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Clinic

1.4 Global Scopolamine Hydrobromide Market Size Estimates and Forecasts

1.4.1 Global Scopolamine Hydrobromide Revenue 2020-2031

1.4.2 Global Scopolamine Hydrobromide Sales 2020-2031

1.4.3 Global Scopolamine Hydrobromide Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Scopolamine Hydrobromide Market Competition by Manufacturers

2.1 Global Scopolamine Hydrobromide Sales Market Share by Manufacturers (2020-2025)

2.2 Global Scopolamine Hydrobromide Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Scopolamine Hydrobromide Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Scopolamine Hydrobromide, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Scopolamine Hydrobromide, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Scopolamine Hydrobromide, Product Type & Application

2.7 Global Key Manufacturers of Scopolamine Hydrobromide, Date of Enter into This Industry

2.8 Global Scopolamine Hydrobromide Market Competitive Situation and Trends

2.8.1 Global Scopolamine Hydrobromide Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Scopolamine Hydrobromide Players Market Share by Revenue

2.8.3 Global Scopolamine Hydrobromide Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Scopolamine Hydrobromide Market Scenario by Region

3.1 Global Scopolamine Hydrobromide Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Scopolamine Hydrobromide Sales by Region: 2020-2031

3.2.1 Global Scopolamine Hydrobromide Sales by Region: 2020-2025

3.2.2 Global Scopolamine Hydrobromide Sales by Region: 2026-2031

3.3 Global Scopolamine Hydrobromide Revenue by Region: 2020-2031

3.3.1 Global Scopolamine Hydrobromide Revenue by Region: 2020-2025

3.3.2 Global Scopolamine Hydrobromide Revenue by Region: 2026-2031

3.4 North America Scopolamine Hydrobromide Market Facts & Figures by Country

3.4.1 North America Scopolamine Hydrobromide Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Scopolamine Hydrobromide Sales by Country (2020-2031)

3.4.3 North America Scopolamine Hydrobromide Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Scopolamine Hydrobromide Market Facts & Figures by Country

3.5.1 Europe Scopolamine Hydrobromide Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Scopolamine Hydrobromide Sales by Country (2020-2031)

3.5.3 Europe Scopolamine Hydrobromide Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Scopolamine Hydrobromide Market Facts & Figures by Region

3.6.1 Asia Pacific Scopolamine Hydrobromide Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Scopolamine Hydrobromide Sales by Region (2020-2031)

3.6.3 Asia Pacific Scopolamine Hydrobromide Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Scopolamine Hydrobromide Market Facts & Figures by Country

3.7.1 Latin America Scopolamine Hydrobromide Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Scopolamine Hydrobromide Sales by Country (2020-2031)

3.7.3 Latin America Scopolamine Hydrobromide Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Scopolamine Hydrobromide Market Facts & Figures by Country

3.8.1 Middle East and Africa Scopolamine Hydrobromide Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Scopolamine Hydrobromide Sales by Country (2020-2031)

3.8.3 Middle East and Africa Scopolamine Hydrobromide Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Scopolamine Hydrobromide Sales by Type (2020-2031)

4.1.1 Global Scopolamine Hydrobromide Sales by Type (2020-2025)

4.1.2 Global Scopolamine Hydrobromide Sales by Type (2026-2031)

4.1.3 Global Scopolamine Hydrobromide Sales Market Share by Type (2020-2031)

4.2 Global Scopolamine Hydrobromide Revenue by Type (2020-2031)

4.2.1 Global Scopolamine Hydrobromide Revenue by Type (2020-2025)

4.2.2 Global Scopolamine Hydrobromide Revenue by Type (2026-2031)

4.2.3 Global Scopolamine Hydrobromide Revenue Market Share by Type (2020-2031)

4.3 Global Scopolamine Hydrobromide Price by Type (2020-2031)

5 Segment by Application

5.1 Global Scopolamine Hydrobromide Sales by Application (2020-2031)

5.1.1 Global Scopolamine Hydrobromide Sales by Application (2020-2025)

5.1.2 Global Scopolamine Hydrobromide Sales by Application (2026-2031)

5.1.3 Global Scopolamine Hydrobromide Sales Market Share by Application (2020-2031)

5.2 Global Scopolamine Hydrobromide Revenue by Application (2020-2031)

5.2.1 Global Scopolamine Hydrobromide Revenue by Application (2020-2025)

5.2.2 Global Scopolamine Hydrobromide Revenue by Application (2026-2031)

5.2.3 Global Scopolamine Hydrobromide Revenue Market Share by Application (2020-2031)

5.3 Global Scopolamine Hydrobromide Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Novartis

6.1.1 Novartis Company Information

6.1.2 Novartis Description and Business Overview

6.1.3 Novartis Scopolamine Hydrobromide Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Novartis Scopolamine Hydrobromide Product Portfolio

6.1.5 Novartis Recent Developments/Updates

6.2 Mylan

6.2.1 Mylan Company Information

6.2.2 Mylan Description and Business Overview

6.2.3 Mylan Scopolamine Hydrobromide Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Mylan Scopolamine Hydrobromide Product Portfolio

6.2.5 Mylan Recent Developments/Updates

6.3 Teva Pharmaceuticals

6.3.1 Teva Pharmaceuticals Company Information

6.3.2 Teva Pharmaceuticals Description and Business Overview

6.3.3 Teva Pharmaceuticals Scopolamine Hydrobromide Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Teva Pharmaceuticals Scopolamine Hydrobromide Product Portfolio

6.3.5 Teva Pharmaceuticals Recent Developments/Updates

6.4 Baxter International

6.4.1 Baxter International Company Information

6.4.2 Baxter International Description and Business Overview

6.4.3 Baxter International Scopolamine Hydrobromide Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Baxter International Scopolamine Hydrobromide Product Portfolio

6.4.5 Baxter International Recent Developments/Updates

6.5 Sandoz

6.5.1 Sandoz Company Information

6.5.2 Sandoz Description and Business Overview

6.5.3 Sandoz Scopolamine Hydrobromide Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Sandoz Scopolamine Hydrobromide Product Portfolio

6.5.5 Sandoz Recent Developments/Updates

6.6 Amgen

6.6.1 Amgen Company Information

6.6.2 Amgen Description and Business Overview

6.6.3 Amgen Scopolamine Hydrobromide Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Amgen Scopolamine Hydrobromide Product Portfolio

6.6.5 Amgen Recent Developments/Updates

6.7 Accord Healthcare

6.7.1 Accord Healthcare Company Information

6.7.2 Accord Healthcare Description and Business Overview

6.7.3 Accord Healthcare Scopolamine Hydrobromide Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Accord Healthcare Scopolamine Hydrobromide Product Portfolio

6.7.5 Accord Healthcare Recent Developments/Updates

6.8 Manus Aktteva Biopharma

6.8.1 Manus Aktteva Biopharma Company Information

6.8.2 Manus Aktteva Biopharma Description and Business Overview

6.8.3 Manus Aktteva Biopharma Scopolamine Hydrobromide Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Manus Aktteva Biopharma Scopolamine Hydrobromide Product Portfolio

6.8.5 Manus Aktteva Biopharma Recent Developments/Updates

6.9 ALKALOIDS CORPORATION

6.9.1 ALKALOIDS CORPORATION Company Information

6.9.2 ALKALOIDS CORPORATION Description and Business Overview

6.9.3 ALKALOIDS CORPORATION Scopolamine Hydrobromide Sales, Revenue and Gross Margin (2020-2025)

6.9.4 ALKALOIDS CORPORATION Scopolamine Hydrobromide Product Portfolio

6.9.5 ALKALOIDS CORPORATION Recent Developments/Updates

6.10 Sigma-Aldrich

6.10.1 Sigma-Aldrich Company Information

6.10.2 Sigma-Aldrich Description and Business Overview

6.10.3 Sigma-Aldrich Scopolamine Hydrobromide Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Sigma-Aldrich Scopolamine Hydrobromide Product Portfolio

6.10.5 Sigma-Aldrich Recent Developments/Updates

6.11 TCI Chemicals

6.11.1 TCI Chemicals Company Information

6.11.2 TCI Chemicals Description and Business Overview

6.11.3 TCI Chemicals Scopolamine Hydrobromide Sales, Revenue and Gross Margin (2020-2025)

6.11.4 TCI Chemicals Scopolamine Hydrobromide Product Portfolio

6.11.5 TCI Chemicals Recent Developments/Updates

6.12 Tocris Bioscience

6.12.1 Tocris Bioscience Company Information

6.12.2 Tocris Bioscience Description and Business Overview

6.12.3 Tocris Bioscience Scopolamine Hydrobromide Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Tocris Bioscience Scopolamine Hydrobromide Product Portfolio

6.12.5 Tocris Bioscience Recent Developments/Updates

6.13 Alchem International

6.13.1 Alchem International Company Information

6.13.2 Alchem International Description and Business Overview

6.13.3 Alchem International Scopolamine Hydrobromide Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Alchem International Scopolamine Hydrobromide Product Portfolio

6.13.5 Alchem International Recent Developments/Updates

6.14 Glentham Life Sciences

6.14.1 Glentham Life Sciences Company Information

6.14.2 Glentham Life Sciences Description and Business Overview

6.14.3 Glentham Life Sciences Scopolamine Hydrobromide Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Glentham Life Sciences Scopolamine Hydrobromide Product Portfolio

6.14.5 Glentham Life Sciences Recent Developments/Updates

6.15 ChemFaces

6.15.1 ChemFaces Company Information

6.15.2 ChemFaces Description and Business Overview

6.15.3 ChemFaces Scopolamine Hydrobromide Sales, Revenue and Gross Margin (2020-2025)

6.15.4 ChemFaces Scopolamine Hydrobromide Product Portfolio

6.15.5 ChemFaces Recent Developments/Updates

6.16 BioCrick

6.16.1 BioCrick Company Information

6.16.2 BioCrick Description and Business Overview

6.16.3 BioCrick Scopolamine Hydrobromide Sales, Revenue and Gross Margin (2020-2025)

6.16.4 BioCrick Scopolamine Hydrobromide Product Portfolio

6.16.5 BioCrick Recent Developments/Updates

6.17 FUJIFILM Wako

6.17.1 FUJIFILM Wako Company Information

6.17.2 FUJIFILM Wako Description and Business Overview

6.17.3 FUJIFILM Wako Scopolamine Hydrobromide Sales, Revenue and Gross Margin (2020-2025)

6.17.4 FUJIFILM Wako Scopolamine Hydrobromide Product Portfolio

6.17.5 FUJIFILM Wako Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Scopolamine Hydrobromide Industry Chain Analysis

7.2 Scopolamine Hydrobromide Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Scopolamine Hydrobromide Production Mode & Process Analysis

7.4 Scopolamine Hydrobromide Sales and Marketing

7.4.1 Scopolamine Hydrobromide Sales Channels

7.4.2 Scopolamine Hydrobromide Distributors

7.5 Scopolamine Hydrobromide Customer Analysis

8 Scopolamine Hydrobromide Market Dynamics

8.1 Scopolamine Hydrobromide Industry Trends

8.2 Scopolamine Hydrobromide Market Drivers

8.3 Scopolamine Hydrobromide Market Challenges

8.4 Scopolamine Hydrobromide Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Manus Aktteva Biopharma

Alkaloids Corporation

Glentham Life Sciences

ChemFaces

BioCrick

FUJIFILM Wako

List of Tables

Table 1. Global Scopolamine Hydrobromide Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Scopolamine Hydrobromide Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Scopolamine Hydrobromide Market Competitive Situation by Manufacturers in 2024

Table 4. Global Scopolamine Hydrobromide Sales (kg) of Key Manufacturers (2020-2025)

Table 5. Global Scopolamine Hydrobromide Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Scopolamine Hydrobromide Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Scopolamine Hydrobromide Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Scopolamine Hydrobromide Average Price (US$/g) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Scopolamine Hydrobromide, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Scopolamine Hydrobromide, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Scopolamine Hydrobromide, Product Type & Application

Table 12. Global Key Manufacturers of Scopolamine Hydrobromide, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Scopolamine Hydrobromide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Scopolamine Hydrobromide as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Scopolamine Hydrobromide Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Scopolamine Hydrobromide Sales by Region (2020-2025) & (kg)

Table 18. Global Scopolamine Hydrobromide Sales Market Share by Region (2020-2025)

Table 19. Global Scopolamine Hydrobromide Sales by Region (2026-2031) & (kg)

Table 20. Global Scopolamine Hydrobromide Sales Market Share by Region (2026-2031)

Table 21. Global Scopolamine Hydrobromide Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Scopolamine Hydrobromide Revenue Market Share by Region (2020-2025)

Table 23. Global Scopolamine Hydrobromide Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Scopolamine Hydrobromide Revenue Market Share by Region (2026-2031)

Table 25. North America Scopolamine Hydrobromide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Scopolamine Hydrobromide Sales by Country (2020-2025) & (kg)

Table 27. North America Scopolamine Hydrobromide Sales by Country (2026-2031) & (kg)

Table 28. North America Scopolamine Hydrobromide Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Scopolamine Hydrobromide Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Scopolamine Hydrobromide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Scopolamine Hydrobromide Sales by Country (2020-2025) & (kg)

Table 32. Europe Scopolamine Hydrobromide Sales by Country (2026-2031) & (kg)

Table 33. Europe Scopolamine Hydrobromide Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Scopolamine Hydrobromide Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Scopolamine Hydrobromide Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Scopolamine Hydrobromide Sales by Region (2020-2025) & (kg)

Table 37. Asia Pacific Scopolamine Hydrobromide Sales by Region (2026-2031) & (kg)

Table 38. Asia Pacific Scopolamine Hydrobromide Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Scopolamine Hydrobromide Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Scopolamine Hydrobromide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Scopolamine Hydrobromide Sales by Country (2020-2025) & (kg)

Table 42. Latin America Scopolamine Hydrobromide Sales by Country (2026-2031) & (kg)

Table 43. Latin America Scopolamine Hydrobromide Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Scopolamine Hydrobromide Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Scopolamine Hydrobromide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Scopolamine Hydrobromide Sales by Country (2020-2025) & (kg)

Table 47. Middle East and Africa Scopolamine Hydrobromide Sales by Country (2026-2031) & (kg)

Table 48. Middle East and Africa Scopolamine Hydrobromide Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Scopolamine Hydrobromide Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Scopolamine Hydrobromide Sales (kg) by Type (2020-2025)

Table 51. Global Scopolamine Hydrobromide Sales (kg) by Type (2026-2031)

Table 52. Global Scopolamine Hydrobromide Sales Market Share by Type (2020-2025)

Table 53. Global Scopolamine Hydrobromide Sales Market Share by Type (2026-2031)

Table 54. Global Scopolamine Hydrobromide Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Scopolamine Hydrobromide Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Scopolamine Hydrobromide Revenue Market Share by Type (2020-2025)

Table 57. Global Scopolamine Hydrobromide Revenue Market Share by Type (2026-2031)

Table 58. Global Scopolamine Hydrobromide Price (US$/g) by Type (2020-2025)

Table 59. Global Scopolamine Hydrobromide Price (US$/g) by Type (2026-2031)

Table 60. Global Scopolamine Hydrobromide Sales (kg) by Application (2020-2025)

Table 61. Global Scopolamine Hydrobromide Sales (kg) by Application (2026-2031)

Table 62. Global Scopolamine Hydrobromide Sales Market Share by Application (2020-2025)

Table 63. Global Scopolamine Hydrobromide Sales Market Share by Application (2026-2031)

Table 64. Global Scopolamine Hydrobromide Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Scopolamine Hydrobromide Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Scopolamine Hydrobromide Revenue Market Share by Application (2020-2025)

Table 67. Global Scopolamine Hydrobromide Revenue Market Share by Application (2026-2031)

Table 68. Global Scopolamine Hydrobromide Price (US$/g) by Application (2020-2025)

Table 69. Global Scopolamine Hydrobromide Price (US$/g) by Application (2026-2031)

Table 70. Novartis Company Information

Table 71. Novartis Description and Business Overview

Table 72. Novartis Scopolamine Hydrobromide Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 73. Novartis Scopolamine Hydrobromide Product

Table 74. Novartis Recent Developments/Updates

Table 75. Mylan Company Information

Table 76. Mylan Description and Business Overview

Table 77. Mylan Scopolamine Hydrobromide Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 78. Mylan Scopolamine Hydrobromide Product

Table 79. Mylan Recent Developments/Updates

Table 80. Teva Pharmaceuticals Company Information

Table 81. Teva Pharmaceuticals Description and Business Overview

Table 82. Teva Pharmaceuticals Scopolamine Hydrobromide Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 83. Teva Pharmaceuticals Scopolamine Hydrobromide Product

Table 84. Teva Pharmaceuticals Recent Developments/Updates

Table 85. Baxter International Company Information

Table 86. Baxter International Description and Business Overview

Table 87. Baxter International Scopolamine Hydrobromide Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 88. Baxter International Scopolamine Hydrobromide Product

Table 89. Baxter International Recent Developments/Updates

Table 90. Sandoz Company Information

Table 91. Sandoz Description and Business Overview

Table 92. Sandoz Scopolamine Hydrobromide Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 93. Sandoz Scopolamine Hydrobromide Product

Table 94. Sandoz Recent Developments/Updates

Table 95. Amgen Company Information

Table 96. Amgen Description and Business Overview

Table 97. Amgen Scopolamine Hydrobromide Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 98. Amgen Scopolamine Hydrobromide Product

Table 99. Amgen Recent Developments/Updates

Table 100. Accord Healthcare Company Information

Table 101. Accord Healthcare Description and Business Overview

Table 102. Accord Healthcare Scopolamine Hydrobromide Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 103. Accord Healthcare Scopolamine Hydrobromide Product

Table 104. Accord Healthcare Recent Developments/Updates

Table 105. Manus Aktteva Biopharma Company Information

Table 106. Manus Aktteva Biopharma Description and Business Overview

Table 107. Manus Aktteva Biopharma Scopolamine Hydrobromide Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 108. Manus Aktteva Biopharma Scopolamine Hydrobromide Product

Table 109. Manus Aktteva Biopharma Recent Developments/Updates

Table 110. ALKALOIDS CORPORATION Company Information

Table 111. ALKALOIDS CORPORATION Description and Business Overview

Table 112. ALKALOIDS CORPORATION Scopolamine Hydrobromide Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 113. ALKALOIDS CORPORATION Scopolamine Hydrobromide Product

Table 114. ALKALOIDS CORPORATION Recent Developments/Updates

Table 115. Sigma-Aldrich Company Information

Table 116. Sigma-Aldrich Description and Business Overview

Table 117. Sigma-Aldrich Scopolamine Hydrobromide Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 118. Sigma-Aldrich Scopolamine Hydrobromide Product

Table 119. Sigma-Aldrich Recent Developments/Updates

Table 120. TCI Chemicals Company Information

Table 121. TCI Chemicals Description and Business Overview

Table 122. TCI Chemicals Scopolamine Hydrobromide Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 123. TCI Chemicals Scopolamine Hydrobromide Product

Table 124. TCI Chemicals Recent Developments/Updates

Table 125. Tocris Bioscience Company Information

Table 126. Tocris Bioscience Description and Business Overview

Table 127. Tocris Bioscience Scopolamine Hydrobromide Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 128. Tocris Bioscience Scopolamine Hydrobromide Product

Table 129. Tocris Bioscience Recent Developments/Updates

Table 130. Alchem International Company Information

Table 131. Alchem International Description and Business Overview

Table 132. Alchem International Scopolamine Hydrobromide Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 133. Alchem International Scopolamine Hydrobromide Product

Table 134. Alchem International Recent Developments/Updates

Table 135. Glentham Life Sciences Company Information

Table 136. Glentham Life Sciences Description and Business Overview

Table 137. Glentham Life Sciences Scopolamine Hydrobromide Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 138. Glentham Life Sciences Scopolamine Hydrobromide Product

Table 139. Glentham Life Sciences Recent Developments/Updates

Table 140. ChemFaces Company Information

Table 141. ChemFaces Description and Business Overview

Table 142. ChemFaces Scopolamine Hydrobromide Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 143. ChemFaces Scopolamine Hydrobromide Product

Table 144. ChemFaces Recent Developments/Updates

Table 145. BioCrick Company Information

Table 146. BioCrick Description and Business Overview

Table 147. BioCrick Scopolamine Hydrobromide Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 148. BioCrick Scopolamine Hydrobromide Product

Table 149. BioCrick Recent Developments/Updates

Table 150. FUJIFILM Wako Company Information

Table 151. FUJIFILM Wako Description and Business Overview

Table 152. FUJIFILM Wako Scopolamine Hydrobromide Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 153. FUJIFILM Wako Scopolamine Hydrobromide Product

Table 154. FUJIFILM Wako Recent Developments/Updates

Table 155. Key Raw Materials Lists

Table 156. Raw Materials Key Suppliers Lists

Table 157. Scopolamine Hydrobromide Distributors List

Table 158. Scopolamine Hydrobromide Customers List

Table 159. Scopolamine Hydrobromide Market Trends

Table 160. Scopolamine Hydrobromide Market Drivers

Table 161. Scopolamine Hydrobromide Market Challenges

Table 162. Scopolamine Hydrobromide Market Restraints

Table 163. Research Programs/Design for This Report

Table 164. Key Data Information from Secondary Sources

Table 165. Key Data Information from Primary Sources

Table 166. Authors List of This Report

List of Figures

Figure 1. Product Picture of Scopolamine Hydrobromide

Figure 2. Global Scopolamine Hydrobromide Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Scopolamine Hydrobromide Market Share by Type: 2024 & 2031

Figure 4. Injections Product Picture

Figure 5. Oral Product Picture

Figure 6. Topical Product Picture

Figure 7. Global Scopolamine Hydrobromide Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Scopolamine Hydrobromide Market Share by Application: 2024 & 2031

Figure 9. Hospital

Figure 10. Clinic

Figure 11. Global Scopolamine Hydrobromide Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Scopolamine Hydrobromide Market Size (2020-2031) & (US$ Million)

Figure 13. Global Scopolamine Hydrobromide Sales (2020-2031) & (kg)

Figure 14. Global Scopolamine Hydrobromide Average Price (US$/g) & (2020-2031)

Figure 15. Scopolamine Hydrobromide Report Years Considered

Figure 16. Scopolamine Hydrobromide Sales Share by Manufacturers in 2024

Figure 17. Global Scopolamine Hydrobromide Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Scopolamine Hydrobromide Players: Market Share by Revenue in Scopolamine Hydrobromide in 2024

Figure 19. Scopolamine Hydrobromide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Scopolamine Hydrobromide Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Scopolamine Hydrobromide Sales Market Share by Country (2020-2031)

Figure 22. North America Scopolamine Hydrobromide Revenue Market Share by Country (2020-2031)

Figure 23. United States Scopolamine Hydrobromide Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Scopolamine Hydrobromide Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Scopolamine Hydrobromide Sales Market Share by Country (2020-2031)

Figure 26. Europe Scopolamine Hydrobromide Revenue Market Share by Country (2020-2031)

Figure 27. Germany Scopolamine Hydrobromide Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Scopolamine Hydrobromide Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Scopolamine Hydrobromide Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Scopolamine Hydrobromide Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Scopolamine Hydrobromide Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Scopolamine Hydrobromide Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Scopolamine Hydrobromide Revenue Market Share by Region (2020-2031)

Figure 34. China Scopolamine Hydrobromide Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Scopolamine Hydrobromide Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Scopolamine Hydrobromide Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Scopolamine Hydrobromide Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Scopolamine Hydrobromide Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. China Taiwan Scopolamine Hydrobromide Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Scopolamine Hydrobromide Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Latin America Scopolamine Hydrobromide Sales Market Share by Country (2020-2031)

Figure 42. Latin America Scopolamine Hydrobromide Revenue Market Share by Country (2020-2031)

Figure 43. Mexico Scopolamine Hydrobromide Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Brazil Scopolamine Hydrobromide Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Argentina Scopolamine Hydrobromide Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Colombia Scopolamine Hydrobromide Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Middle East and Africa Scopolamine Hydrobromide Sales Market Share by Country (2020-2031)

Figure 48. Middle East and Africa Scopolamine Hydrobromide Revenue Market Share by Country (2020-2031)

Figure 49. Turkey Scopolamine Hydrobromide Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Scopolamine Hydrobromide Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. UAE Scopolamine Hydrobromide Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Global Sales Market Share of Scopolamine Hydrobromide by Type (2020-2031)

Figure 53. Global Revenue Market Share of Scopolamine Hydrobromide by Type (2020-2031)

Figure 54. Global Scopolamine Hydrobromide Price (US$/g) by Type (2020-2031)

Figure 55. Global Sales Market Share of Scopolamine Hydrobromide by Application (2020-2031)

Figure 56. Global Revenue Market Share of Scopolamine Hydrobromide by Application (2020-2031)

Figure 57. Global Scopolamine Hydrobromide Price (US$/g) by Application (2020-2031)

Figure 58. Scopolamine Hydrobromide Value Chain

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions